Skip to main content
Clinical Trials/NCT05472987
NCT05472987
Recruiting
Not Applicable

Robotic Versus Open Ventral Hernia Repair: A Randomized Controlled Trial

Lucas Beffa4 sites in 1 country200 target enrollmentJuly 25, 2022
ConditionsVentral Hernia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ventral Hernia
Sponsor
Lucas Beffa
Enrollment
200
Locations
4
Primary Endpoint
Length of Stay
Status
Recruiting
Last Updated
6 months ago

Overview

Brief Summary

This is a randomized trial comparing open retromuscular ventral hernia repair to robotic retromuscular ventral hernia repair.

Detailed Description

This is a randomized trial comparing open retromuscular ventral hernia repair to robotic retromuscular ventral hernia repair. This is a superiority trial with a primary outcome of length of stay in the hospital, theorizing that robotic retromuscular ventral hernia repairs are superior to open ventral hernia repairs by reducing length of stay by 24 hours. Patients will be blinded to the intervention, groups will be in parallel, and the primary outcome (when the patient is discharged) will be determined by a blinded assessor.

Registry
clinicaltrials.gov
Start Date
July 25, 2022
End Date
August 1, 2027
Last Updated
6 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Lucas Beffa
Responsible Party
Sponsor Investigator
Principal Investigator

Lucas Beffa

Assistant Professor of Surgery

The Cleveland Clinic

Eligibility Criteria

Inclusion Criteria

  • 18 years and older
  • 7 cm to 15 cm wide hernia midline defects
  • BMI less than or equal to 45
  • Patient deemed both an open and robotic candidate by operating surgeon

Exclusion Criteria

  • 17 years old or younger
  • prisoners
  • pregnant patients
  • Emergent patients
  • BMI greater than 45
  • Hernia defects less than 7 cm or greater than 15 cm in width

Outcomes

Primary Outcomes

Length of Stay

Time Frame: 30 days

Time in the hospital after the surgery

Secondary Outcomes

  • Opioid consumption(30 days and one year)
  • Post-operative wound complications(30 day and one year)
  • Readmission rate(30 days)
  • Acute pain scores(5 days after surgery)
  • Hernia recurrence(30 days and one year)
  • Quality of life scores using European Hernia Society (EuraHS) scale(30 day and one year)
  • Other post operative complications(30 days)
  • Direct cost(30 days)
  • Hernia Related Specific Quality of Life Score(30 days and one year)

Study Sites (4)

Loading locations...

Similar Trials